ScholarLens Back to search
2018•Journal watchRequires access

Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Neuromyelitis Optica Spectrum Disorder

Robert T. Naismith

Open publisher page 0 citations

Abstract

Several syndromes have been described with associated myelin oligodendrocyte glycoprotein (MOG) antibodies (Abs). The studies evaluating prognosis in

About this research paper

What this paper is about

Several syndromes have been described with associated myelin oligodendrocyte glycoprotein (MOG) antibodies (Abs). The studies evaluating prognosis in

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Several syndromes have been described with associated myelin oligodendrocyte glycoprotein (MOG) antibodies (Abs). The studies evaluating prognosis in

Key concepts: Neuromyelitis optica, Myelin oligodendrocyte glycoprotein, Spectrum disorder, Medicine, Oligodendrocyte, Myelin, Multiple sclerosis, Demyelinating Disorder

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Neuromyelitis Optica Spectrum Disorder — Research Paper | ScholarLens